• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植肝内铁稳态相关基因的表达可预测人类肝移植术后获得性免疫耐受的发生。

Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.

机构信息

Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain.

出版信息

J Clin Invest. 2012 Jan;122(1):368-82. doi: 10.1172/JCI59411. Epub 2011 Dec 12.

DOI:10.1172/JCI59411
PMID:22156196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3248302/
Abstract

Following organ transplantation, lifelong immunosuppressive therapy is required to prevent the host immune system from destroying the allograft. This can cause severe side effects and increased recipient morbidity and mortality. Complete cessation of immunosuppressive drugs has been successfully accomplished in selected transplant recipients, providing proof of principle that operational allograft tolerance is attainable in clinical transplantation. The intra-graft molecular pathways associated with successful drug withdrawal, however, are not well defined. In this study, we analyzed sequential blood and liver tissue samples collected from liver transplant recipients enrolled in a prospective multicenter immunosuppressive drug withdrawal clinical trial. Before initiation of drug withdrawal, operationally tolerant and non-tolerant recipients differed in the intra-graft expression of genes involved in the regulation of iron homeostasis. Furthermore, as compared with non-tolerant recipients, operationally tolerant patients exhibited higher serum levels of hepcidin and ferritin and increased hepatocyte iron deposition. Finally, liver tissue gene expression measurements accurately predicted the outcome of immunosuppressive withdrawal in an independent set of patients. These results point to a critical role for iron metabolism in the regulation of intra-graft alloimmune responses in humans and provide a set of biomarkers to conduct drug-weaning trials in liver transplantation.

摘要

器官移植后,需要终身使用免疫抑制疗法来防止宿主免疫系统破坏移植物。这会导致严重的副作用,并增加受者的发病率和死亡率。在选定的移植受者中,已成功实现完全停止免疫抑制药物治疗,这为临床移植中获得操作性移植物耐受提供了原理证明。然而,与成功停药相关的移植物内分子途径尚未得到很好的定义。在这项研究中,我们分析了前瞻性多中心免疫抑制药物停药临床试验中入组的肝移植受者的连续血样和肝组织样本。在开始停药之前,操作性耐受和非耐受受者在调节铁稳态的基因在移植物内的表达上存在差异。此外,与非耐受受者相比,操作性耐受患者的血清铁调素和铁蛋白水平升高,肝细胞铁沉积增加。最后,肝组织基因表达测量在一组独立的患者中准确预测了免疫抑制停药的结果。这些结果表明,铁代谢在调节人类移植物同种免疫反应中起关键作用,并提供了一组生物标志物,可用于进行肝移植中的药物脱瘾试验。

相似文献

1
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.移植肝内铁稳态相关基因的表达可预测人类肝移植术后获得性免疫耐受的发生。
J Clin Invest. 2012 Jan;122(1):368-82. doi: 10.1172/JCI59411. Epub 2011 Dec 12.
2
Multiparameter immune profiling of operational tolerance in liver transplantation.肝移植中手术耐受的多参数免疫分析
Am J Transplant. 2007 Feb;7(2):309-19. doi: 10.1111/j.1600-6143.2006.01621.x.
3
[Development of immune tolerance in liver transplantation].[肝移植中免疫耐受的发展]
Gastroenterol Hepatol. 2011 Mar;34(3):155-69. doi: 10.1016/j.gastrohep.2010.11.007. Epub 2011 Mar 3.
4
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.前瞻性多中心临床试验:免疫抑制剂在稳定期成人肝移植受者中的停药。
Hepatology. 2013 Nov;58(5):1824-35. doi: 10.1002/hep.26426. Epub 2013 Sep 19.
5
Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial.评价一种基因表达生物标志物以识别具有操作性耐受力的肝移植受者:LITMUS 试验。
Clin Exp Immunol. 2022 Jan 28;207(1):123-139. doi: 10.1093/cei/uxab011.
6
Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.移植耐受的特征表明了尽量减少免疫抑制的机会。
Clin Biochem. 2016 Mar;49(4-5):404-10. doi: 10.1016/j.clinbiochem.2016.01.007. Epub 2016 Jan 13.
7
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.利用转录谱分析开发肝移植受者手术耐受的诊断测试。
J Clin Invest. 2008 Aug;118(8):2845-57. doi: 10.1172/JCI35342.
8
Identification of tolerant recipients following liver transplantation.肝移植后耐受受者的鉴定。
Int Immunopharmacol. 2010 Dec;10(12):1501-4. doi: 10.1016/j.intimp.2010.06.011. Epub 2010 Jun 29.
9
Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients.鉴定一组稳定的肾移植患者中与操作性耐受相关的基因表达谱。
Transpl Int. 2011 Jun;24(6):536-47. doi: 10.1111/j.1432-2277.2011.01251.x. Epub 2011 Apr 1.
10
Current Tolerance-Associated Peripheral Blood Gene Expression Profiles After Liver Transplantation Are Influenced by Immunosuppressive Drugs and Prior Cytomegalovirus Infection.当前肝移植后与耐受相关的外周血基因表达谱受免疫抑制剂和既往巨细胞病毒感染的影响。
Front Immunol. 2022 Jan 11;12:738837. doi: 10.3389/fimmu.2021.738837. eCollection 2021.

引用本文的文献

1
Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance.肝移植中免疫抑制的进展:调节性T细胞在免疫调节和移植物耐受中的作用
Clin Transplant Res. 2024 Dec 31;38(4):257-272. doi: 10.4285/ctr.24.0059. Epub 2024 Dec 19.
2
Donor-Specific Blood Transfusion in Lung Transplantation.肺移植中的供者特异性输血。
Transpl Int. 2024 Oct 30;37:12822. doi: 10.3389/ti.2024.12822. eCollection 2024.
3
Computational identification of novel potential genetic pathogenesis and otherwise biomarkers in acute liver allograft rejection.急性肝移植排斥反应中新的潜在遗传发病机制及其他生物标志物的计算识别
Heliyon. 2024 Jun 22;10(15):e33359. doi: 10.1016/j.heliyon.2024.e33359. eCollection 2024 Aug 15.
4
Establishment and validation of a predictive model of immune tolerance after pediatric liver transplantation: a multicenter cohort study.小儿肝移植后免疫耐受预测模型的建立与验证:一项多中心队列研究
Int J Surg. 2024 Sep 1;110(9):5615-5626. doi: 10.1097/JS9.0000000000001671.
5
Have serum vitamin D and ferritin a role in predicting the prognosis of autoimmune hepatitis treatment in children?血清维生素D和铁蛋白在预测儿童自身免疫性肝炎治疗的预后方面有作用吗?
Clin Exp Hepatol. 2024 Mar;10(1):53-61. doi: 10.5114/ceh.2024.136927. Epub 2024 Mar 28.
6
Cell-based therapies for the treatment of rheumatoid arthritis.基于细胞的疗法治疗类风湿关节炎。
Immun Inflamm Dis. 2023 Nov;11(11):e1091. doi: 10.1002/iid3.1091.
7
Basic Understanding of Liver Transplant Immunology.肝脏移植免疫学基础认知
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):1091-1102. doi: 10.1016/j.jceh.2023.05.007. Epub 2023 May 26.
8
How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients.如何评估肝移植受者长期耐受的概率。
J Clin Med. 2023 Oct 16;12(20):6546. doi: 10.3390/jcm12206546.
9
European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.欧洲器官移植学会关于肝移植生物标志物的共识声明。
Transpl Int. 2023 Aug 30;36:11358. doi: 10.3389/ti.2023.11358. eCollection 2023.
10
Contemporary Biomarkers for Renal Transplantation: A Narrative Overview.肾移植的当代生物标志物:叙述性概述
J Pers Med. 2023 Jul 31;13(8):1216. doi: 10.3390/jpm13081216.

本文引用的文献

1
Low hepcidin accounts for the proinflammatory status associated with iron deficiency.低铁调素导致了与缺铁相关的炎症状态。
Blood. 2011 Jul 21;118(3):736-46. doi: 10.1182/blood-2011-02-337212. Epub 2011 May 31.
2
Host-mediated regulation of superinfection in malaria.宿主介导的疟疾再感染调控。
Nat Med. 2011 Jun;17(6):732-7. doi: 10.1038/nm.2368. Epub 2011 May 15.
3
Molecular signatures database (MSigDB) 3.0.分子特征数据库(MSigDB)3.0。
Bioinformatics. 2011 Jun 15;27(12):1739-40. doi: 10.1093/bioinformatics/btr260. Epub 2011 May 5.
4
Serum hepcidin: reference ranges and biochemical correlates in the general population.血清铁调素:普通人群的参考范围和生化相关性。
Blood. 2011 Jun 23;117(25):e218-25. doi: 10.1182/blood-2011-02-337907. Epub 2011 Apr 28.
5
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.肝或其他实体器官移植后排斥和耐受的免疫基础。
Gastroenterology. 2011 Jan;140(1):51-64. doi: 10.1053/j.gastro.2010.10.059. Epub 2010 Nov 9.
6
Antigen-presenting cell function in the tolerogenic liver environment.抗原提呈细胞在耐受原性肝环境中的功能。
Nat Rev Immunol. 2010 Nov;10(11):753-66. doi: 10.1038/nri2858.
7
Hepcidin and disorders of iron metabolism.亚铁调素与铁代谢紊乱。
Annu Rev Med. 2011;62:347-60. doi: 10.1146/annurev-med-050109-142444.
8
SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.SOCS1,细胞因子信号和 TLR 反应的负调节剂,在人类肝脏疾病中的作用。
Gastroenterol Res Pract. 2010;2010. doi: 10.1155/2010/470468. Epub 2010 Sep 2.
9
Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study.献血者的缺铁情况:来自 REDS-II 献血者铁状态评估研究(RISE)入组数据的分析。
Transfusion. 2011 Mar;51(3):511-22. doi: 10.1111/j.1537-2995.2010.02865.x. Epub 2010 Aug 30.
10
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.基于免疫化学和质谱的血清铁调素检测在铁代谢紊乱中的应用。
Clin Chem. 2010 Oct;56(10):1570-9. doi: 10.1373/clinchem.2010.149187. Epub 2010 Aug 25.